We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$79.9B
AUM Growth
+$16.7B
Cap. Flow
+$9.74B
Cap. Flow %
12.19%
Top 10 Hldgs %
13.34%
Holding
4,935
New
829
Increased
1,631
Reduced
1,587
Closed
796

Sector Composition

Rank Sector Weight
1 Healthcare 10.45%
2 Technology 8.65%
3 Financials 8.6%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLO
4001
Clough Global Opportunities Fund
GLO
$246M
$95K ﹤0.01%
+10,085
New +$93.4K
INFU icon
4002
InfuSystem Holdings
INFU
$238M
$95K ﹤0.01%
+11,153
New +$82.1K
USAS
4003
Americas Gold and Silver
USAS
$1.82B
$95K ﹤0.01%
+11,979
New +$85.5K
IVAC
4004
DELISTED
Intevac Inc
IVAC
$95K ﹤0.01%
13,449
-4,012
-23% -$23.5K
TKC icon
4005
Turkcell
TKC
$4.72B
$94K ﹤0.01%
+16,194
New +$92.4K
GRCE
4006
Grace Therapeutics
GRCE
$45.9M
$94K ﹤0.01%
+803
New +$79.3K
KZR
4007
DELISTED
Kezar Life Sciences
KZR
$92K ﹤0.01%
2,301
+795
+53% +$24.5K
GNCA
4008
DELISTED
Genocea Biosciences, Inc.
GNCA
$91K ﹤0.01%
43,883
-72,963
-62% -$173K
STGW icon
4009
Stagwell
STGW
$2.17B
$90K ﹤0.01%
+32,550
New +$87.7K
QTT
4010
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$89K ﹤0.01%
2,610
-3,079
-54% -$103K
MBRX icon
4011
Moleculin Biotech
MBRX
$11.9M
$88K ﹤0.01%
43
-52
-55% -$122K
GLMD icon
4012
Galmed Pharmaceuticals
GLMD
$4.22M
$87K ﹤0.01%
+10
New +$68.7K
ESTE
4013
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$87K ﹤0.01%
13,717
-2,807
-17% -$13.2K
VRDN icon
4014
Viridian Therapeutics
VRDN
$2.72B
$86K ﹤0.01%
11,993
-14,724
-55% -$151K
FSTX
4015
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$85K ﹤0.01%
13,517
-11,502
-46% -$146K
NVAX icon
4016
Novavax
NVAX
$1.46B
$83K ﹤0.01%
20,854
+6,932
+50% +$30.1K
SVRA icon
4017
Savara
SVRA
$1.14B
$81K ﹤0.01%
17,994
-71,938
-80% -$86.6K
FCRD
4018
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$81K ﹤0.01%
+12,887
New +$87K
VAL
4019
DELISTED
Valaris plc Class A Ordinary Share
VAL
$81K ﹤0.01%
+12,358
New +$60.2K
AEYE icon
4020
AudioEye
AEYE
$91.9M
$80K ﹤0.01%
17,116
-14,686
-46% -$62K
HCR
4021
DELISTED
Hi-Crush Inc. Common Stock
HCR
$80K ﹤0.01%
+91,114
New +$96.1K
RLGT icon
4022
Radiant Logistics
RLGT
$395M
$79K ﹤0.01%
14,233
-15,759
-53% -$85.2K
NSCO.WS
4023
CALL
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
$79K ﹤0.01%
+19,246
New +$10.6K
IRS
4024
IRSA Inversiones y Representaciones
IRS
$1.28B
$76K ﹤0.01%
10,580
-77,760
-88% -$446K
TUES
4025
DELISTED
Tuesday Morning Corp
TUES
$75K ﹤0.01%
40,468
-38,317
-49% -$61K

Similar funds

Israel Englander's Q4 2019 Portfolio in Review

As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.

  • Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
  • Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
  • Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
  • Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
  • Israel Englander opened 829 new positions and closed 796 in Q4 2019.
  • Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.